Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance and University of Manchester, Manchester, UK.
Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Clin Rehabil. 2023 Jun;37(6):808-835. doi: 10.1177/02692155221144554. Epub 2022 Dec 20.
Acceptance and Commitment Therapy interventions are increasing in use in neurological populations. There is a lack of information on the measures available.
To identify and classify the measures used in Acceptance and Commitment Therapy research studies with adults with acquired neurological conditions.
PRISMA-ScR guided scoping review. MEDLINE, PsycInfo and CINAHL databases searched (up to date 29/06/2022) with forward and backward searching. All study types included. Extraction of Acceptance and Commitment Therapy process-of-change and health-related outcome measures. Outcomes coded using the Core Outcome Measures in Effectiveness Trials (COMET) taxonomy.
Three hundred and thirty three papers found on searching. Fifty four studies included and 136 measurement tools extracted. Conditions included multiple sclerosis, traumatic brain injury and stroke. Thirty-eight studies measured processes of change, with 32 measures extracted. The process measure most often used was the Acceptance and Action Questionnaire ( = 21 studies). One hundred and four health-related outcome measures extracted. Measures exploring quality of life, health status, anxiety and depression occurred most frequently, and were used in all included neurological conditions. COMET domains most frequently coded were emotional functioning/well-being ( = 50), physical functioning ( = 32), role functioning ( = 22) and psychiatric ( = 22).
This study provides a resource to support future identification of candidate measures. This could aid development of a Core Outcome Set to support both research and clinical practice. Further research to identify the most appropriate and relevant targets and tools for use in these populations should include expert consensus, patient, carer and public involvement and psychometric examination of measures.
接受和承诺疗法干预措施在神经科人群中的应用越来越多。但目前缺乏相关信息。
确定和分类用于成人获得性神经疾病接受和承诺疗法研究的测量工具。
采用 PRISMA-ScR 指导的范围综述。检索 MEDLINE、PsycInfo 和 CINAHL 数据库（截至 2022 年 6 月 29 日），并进行前向和后向搜索。纳入所有研究类型。提取接受和承诺疗法的过程变化和与健康相关的结果测量。使用有效性试验核心结局测量（COMET）分类法对结果进行编码。
通过搜索发现 333 篇论文。纳入 54 项研究，提取了 136 种测量工具。纳入的疾病包括多发性硬化症、创伤性脑损伤和中风。38 项研究测量了变化过程，提取了 32 种测量工具。使用最频繁的过程测量工具是接受和行动问卷（ = 21 项研究）。提取了 104 种与健康相关的结果测量。评估生活质量、健康状况、焦虑和抑郁的测量工具最常使用，且适用于所有纳入的神经疾病。COMET 编码最常出现的领域是情绪功能/幸福感（ = 50）、身体功能（ = 32）、角色功能（ = 22）和精神健康（ = 22）。
本研究为未来确定候选测量工具提供了资源。这有助于制定核心结局集，以支持研究和临床实践。为了在这些人群中确定最合适和最相关的目标和工具，进一步的研究应包括专家共识、患者、照顾者和公众的参与以及对测量工具的心理测量学评估。
